# A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers

> **NCT01358006** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 13 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-40411813
- **DRUG:** JNJ-40411813

## Key facts

- **NCT ID:** NCT01358006
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2013-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358006, "A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01358006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*